Why Neurocrine Biosciences Stock Is Jumping Today
Shares of Neurocrine Biosciences (NASDAQ: NBIX) were trading almost 10% higher as of 12:20 p.m. EDT Tuesday after the biotech company announced better-than-expected second-quarter results after the market closed on Monday.
One good quarter (or one bad quarter, for that matter) doesn't really mean a lot in the grand scheme of things. However, for a small biotech with its first drug on the market, an exceptionally strong quarter can significantly improve investors' confidence. That's what is happening with Neurocrine.
Image source: Getty Images.
Quelle Fool.com
